Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

NCT00563927 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

340

Enrollment

OTHER_GOV

Sponsor class

Conditions

Nasopharyngeal Neoplasms
Carcinoma, Squamous Cell

Interventions

PROCEDURE: Conventional RT
DRUG: Cisplatin
DRUG: 5-fluorouracil

Sponsor

Hospital Authority, Hong Kong

Collaborators

[object Object]